Talmadge JE - Search Results

1

Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor as a possible mechanism of action.

Badger AM, Olivera D, Talmadge JE, Hanna N. Badger AM, et al. Among authors: talmadge je. Circ Shock. 1989 Jan;27(1):51-61. Circ Shock. 1989. PMID: 2492908

2

Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes.

Badger AM, Dimartino MJ, Talmadge JE, Picker DH, Schwartz DA, Dorman JW, Mirabelli CK, Hanna N. Badger AM, et al. Among authors: talmadge je. Int J Immunopharmacol. 1989;11(7):839-46. doi: 10.1016/0192-0561(89)90138-0. Int J Immunopharmacol. 1989. PMID: 2532178

3

Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5.

King AG, Talmadge JE, Badger AM, Pelus LM. King AG, et al. Among authors: talmadge je. Exp Hematol. 1992 Feb;20(2):223-8. Exp Hematol. 1992. PMID: 1544391

4

Induction of non-specific suppressor cells and myeloregulatory effects of an immunomodulatory azaspirane, SK&F 105685.

King AG, Olivera D, Talmadge JE, Badger AM. King AG, et al. Among authors: talmadge je. Int J Immunopharmacol. 1991;13(1):91-100. doi: 10.1016/0192-0561(91)90029-7. Int J Immunopharmacol. 1991. PMID: 1827431

5

Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685.

Badger AM, King AG, Talmadge JE, Schwartz DA, Picker DH, Mirabelli CK, Hanna N. Badger AM, et al. Among authors: talmadge je. J Autoimmun. 1990 Aug;3(4):485-500. doi: 10.1016/s0896-8411(05)80015-0. J Autoimmun. 1990. PMID: 2145847

6

Development of myelorestorative and immunotherapeutic properties of cytokines.

Talmadge JE, Bloom J, Black P, Badger A. Talmadge JE, et al. Prog Clin Biol Res. 1990;354A:271-85. Prog Clin Biol Res. 1990. PMID: 2247492 Review. No abstract available.

7

Therapeutic properties of biological response modifiers. A discussion of preclinical and clinical studies.

Talmadge JE. Talmadge JE. Contrib Gynecol Obstet. 1989;17:49-62. Contrib Gynecol Obstet. 1989. PMID: 2495895 Review. No abstract available.

8

Immunomodulatory and therapeutic properties of FK-565 in mice.

Talmadge JE, Lenz B, Schneider M, Phillips H, Long C. Talmadge JE, et al. Cancer Immunol Immunother. 1989;28(2):93-100. doi: 10.1007/BF00199108. Cancer Immunol Immunother. 1989. PMID: 2521814 Free PMC article.

9

Development of immunotherapeutic strategies for the treatment of malignant neoplasia.

Talmadge JE. Talmadge JE. Pathol Immunopathol Res. 1989;8(5-6):250-75. doi: 10.1159/000157155. Pathol Immunopathol Res. 1989. PMID: 2699034 Review.

10

Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice.

Talmadge JE, Black PL, Pelus LM, Abe F. Talmadge JE, et al. Biomed Pharmacother. 1990;44(2):85-91. doi: 10.1016/0753-3322(90)90109-m. Biomed Pharmacother. 1990. PMID: 2224059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters